Patents by Inventor Sylvia Els-Heindl

Sylvia Els-Heindl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230303647
    Abstract: The present invention relates to cyclic chemerin-9 derivatives of general formula (I) as described and defined herein, methods of preparing said peptides, and the use of said compounds for the treatment or prophylaxis of diseases, in particular cancer, diabetes, obesity and inflammatory disorders.
    Type: Application
    Filed: August 10, 2021
    Publication date: September 28, 2023
    Applicant: Bayer Aktiengesellschaft
    Inventors: Jan Robert KRÄHLING, Bernd RIEDL, Annette BECK-SICKINGER, Tobias FISCHER, Anne CZERNIAK, Sylvia ELS-HEINDL
  • Publication number: 20220387608
    Abstract: The invention relates to stabilized Adrenomedullin derivatives and use thereof. In particular, the invention relates to novel, biologically active, stabilized Adrenomedullin (ADM) compounds. The invention further relates to the compounds for use in a method for the treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders, and to medicaments comprising the compounds for treatment and/or prevention of cardiovascular, edematous and/or inflammatory disorders.
    Type: Application
    Filed: June 12, 2020
    Publication date: December 8, 2022
    Applicant: Bayer Aktiengesellschaft
    Inventors: Johannes KÖBBERLING, Donald BIERER, Ingo FLAMME, Bernd RIEDL, Lucas Hudson HOFMEISTER, Annette BECK-SICKINGER, Sylvia ELS-HEINDL, Jan-Patrick FISCHER, Eva-Maria JÜLKE
  • Patent number: 9718861
    Abstract: The present invention relates to highly potent ligands at the ghrelin receptor to influence food intake or other conditions.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: August 1, 2017
    Assignee: Universitaet Leipzig
    Inventors: Annette Beck-Sickinger, Sylvia Els-Heindl, Enrico Schild, Thue W. Schwartz, Birgitte Holst Lange
  • Publication number: 20150274781
    Abstract: The present invention relates to highly potent ligands at the ghrelin receptor to influence food intake or other conditions.
    Type: Application
    Filed: August 24, 2012
    Publication date: October 1, 2015
    Applicant: Universitaet Leipzig
    Inventors: Annette Beck-Sickinger, Sylvia Els-Heindl, Enrico Schild, Thue W. Schwartz, Birgitte Holst Lange